Toshio Kakuda
Papers
2
Total Citations
5
H-Index
1
About
Toshio Kakuda is a urologic surgeon and researcher specializing in robotic-assisted oncologic surgery for high-risk prostate and renal cancers. His work focuses on expanding the boundaries of minimally invasive techniques to treat aggressive malignancies where surgery alone was once considered insufficient. In a landmark 2021 study, Kakuda demonstrated that extended robot-assisted laparoscopic prostatectomy with extended pelvic lymph node dissection can serve as a monotherapy for patients with very-high-risk prostate cancer, challenging the necessity of neoadjuvant or adjuvant therapies. This work, cited 4 times, addresses a critical gap in managing patients with earlier biochemical recurrences and higher mortality rates. More recently, in 2024, he reported a novel case of robot-assisted radical nephrectomy and inferior vena cava thrombectomy following combination immunotherapy with pembrolizumab and axitinib for renal cell carcinoma, showcasing the integration of advanced systemic therapies with robotic surgery. Though his citation counts are modest, Kakuda’s contributions are pioneering in their clinical ambition, offering new pathways for treating complex urologic cancers. His research is particularly valuable for surgeons and oncologists seeking to optimize outcomes through tailored, less invasive approaches.
Research Focus
Key Achievements
Top Papers
- 1
- 2